CS202506B2 - Process for preparing new 2-pyridyl- a 2-pyrimidylaminobenzoic acids - Google Patents

Process for preparing new 2-pyridyl- a 2-pyrimidylaminobenzoic acids Download PDF

Info

Publication number
CS202506B2
CS202506B2 CS785205A CS520578A CS202506B2 CS 202506 B2 CS202506 B2 CS 202506B2 CS 785205 A CS785205 A CS 785205A CS 520578 A CS520578 A CS 520578A CS 202506 B2 CS202506 B2 CS 202506B2
Authority
CS
Czechoslovakia
Prior art keywords
group
salts
salt
benzene ring
pyridyl
Prior art date
Application number
CS785205A
Other languages
Czech (cs)
English (en)
Inventor
Kurt Schromm
Anton Mentrup
Ernst-Otto Renth
Armin Fuegner
Volker Jacobi
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of CS202506B2 publication Critical patent/CS202506B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicinal Preparation (AREA)
CS785205A 1977-08-10 1978-08-09 Process for preparing new 2-pyridyl- a 2-pyrimidylaminobenzoic acids CS202506B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772735919 DE2735919A1 (de) 1977-08-10 1977-08-10 Neue 2-pyridyl- und 2-pyrimidylaminobenzoesaeuren

Publications (1)

Publication Number Publication Date
CS202506B2 true CS202506B2 (en) 1981-01-30

Family

ID=6016013

Family Applications (1)

Application Number Title Priority Date Filing Date
CS785205A CS202506B2 (en) 1977-08-10 1978-08-09 Process for preparing new 2-pyridyl- a 2-pyrimidylaminobenzoic acids

Country Status (32)

Country Link
US (1) US4241068A (hu)
JP (1) JPS5430177A (hu)
AT (1) AT370415B (hu)
AU (1) AU520240B2 (hu)
BE (1) BE869640A (hu)
BG (1) BG30472A1 (hu)
CA (1) CA1111037A (hu)
CH (1) CH649289A5 (hu)
CS (1) CS202506B2 (hu)
DD (1) DD140351A5 (hu)
DE (1) DE2735919A1 (hu)
DK (1) DK148019C (hu)
ES (5) ES472143A1 (hu)
FI (1) FI71555C (hu)
FR (1) FR2400017A1 (hu)
GB (1) GB2002764B (hu)
GR (1) GR65024B (hu)
HU (1) HU179933B (hu)
IE (1) IE47228B1 (hu)
IT (1) IT1107960B (hu)
LU (1) LU80094A1 (hu)
MX (1) MX5672E (hu)
NL (1) NL7808319A (hu)
NO (1) NO152605C (hu)
NZ (1) NZ188101A (hu)
PH (1) PH19117A (hu)
PL (2) PL115778B1 (hu)
PT (1) PT68407A (hu)
SE (1) SE444170B (hu)
SU (2) SU735168A3 (hu)
YU (1) YU40832B (hu)
ZA (1) ZA784501B (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3100516A1 (de) * 1981-01-10 1982-08-12 C.H. Boehringer Sohn, 6507 Ingelheim Pyridylaminobenzoesaeuren, ihre herstellung und verwendung
FR2533567A1 (fr) * 1982-09-23 1984-03-30 Ki I Farmakologii 2-(orthocarboxyphenylamino)-6h-pyrimido (2,1-b)-quinazolone-6 et ses derives, leur procede de preparation et leur application therapeutique
US4610991A (en) * 1983-04-18 1986-09-09 Sterling Drug Inc. Antihypertensive pyridylaminobenzamide compounds
JPS60100559A (ja) * 1983-11-05 1985-06-04 Morishita Seiyaku Kk 2−アニリノ−1,6−ジヒドロ−6−オキソ−5−ピリミジンカルボン酸誘導体,その製法及び該化合物を含有する抗アレルギ−剤
US4584379A (en) * 1985-01-22 1986-04-22 Merrell Dow Pharmaceuticals Inc. Isoquinoline thromboxane synthetase inhibitors
DE3682160D1 (de) * 1985-10-16 1991-11-28 Merck Frosst Canada Inc 2-substituierte chinoline.
GB9615950D0 (en) * 1996-07-30 1996-09-11 Univ Warwick Variable reluctance machines
US6022884A (en) 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1064259A (en) * 1963-12-19 1967-04-05 Union Pharma Scient Appl New derivatives of 2-anilino-nicotinic acid and process for their preparation
GB1162287A (en) * 1967-11-07 1969-08-20 Union Pharma Scient Appl New Salts of 2-Anilino-Nicotinic Acids
GB1264798A (hu) * 1968-07-10 1972-02-23
ES416847A1 (es) * 1973-07-12 1976-03-01 Hermes Sa Lab Procedimiento para la obtencion de derivados del acido ni- cotinico.

Also Published As

Publication number Publication date
NO152605B (no) 1985-07-15
JPS6231704B2 (hu) 1987-07-09
BG30472A1 (en) 1981-06-15
ES480623A1 (es) 1980-01-01
GB2002764B (en) 1982-08-04
ZA784501B (en) 1980-04-30
DK351978A (da) 1979-02-11
IE47228B1 (en) 1984-01-25
FR2400017A1 (fr) 1979-03-09
MX5672E (es) 1983-12-08
PL115778B1 (en) 1981-04-30
HU179933B (en) 1983-01-28
IT1107960B (it) 1985-12-02
ES475457A1 (es) 1979-11-16
DE2735919C2 (hu) 1988-10-27
FI71555B (fi) 1986-10-10
SU735168A3 (ru) 1980-05-15
AT370415B (de) 1983-03-25
IE781618L (en) 1979-02-10
YU191678A (en) 1983-01-21
FI782039A (fi) 1979-02-11
AU520240B2 (en) 1982-01-21
DK148019C (da) 1985-07-01
BE869640A (fr) 1979-02-09
DD140351A5 (de) 1980-02-27
NL7808319A (nl) 1979-02-13
CH649289A5 (de) 1985-05-15
LU80094A1 (de) 1979-09-07
NO782707L (no) 1979-02-13
FR2400017B1 (hu) 1983-03-11
AU3877278A (en) 1980-02-14
SE7808530L (sv) 1979-02-11
PT68407A (de) 1978-09-01
JPS5430177A (en) 1979-03-06
US4241068A (en) 1980-12-23
PL115889B1 (en) 1981-05-30
IT7850642A0 (it) 1978-08-08
ES472143A1 (es) 1979-03-16
ATA549278A (de) 1982-08-15
SE444170B (sv) 1986-03-24
GB2002764A (en) 1979-02-28
ES480622A1 (es) 1980-01-01
NO152605C (no) 1985-10-23
CA1111037A (en) 1981-10-20
PH19117A (en) 1986-01-06
NZ188101A (en) 1981-01-23
GR65024B (en) 1980-06-16
SU886743A3 (ru) 1981-11-30
DE2735919A1 (de) 1979-02-22
YU40832B (en) 1986-06-30
FI71555C (fi) 1987-01-19
DK148019B (da) 1985-02-04
ES475456A1 (es) 1979-05-01
PL208942A1 (hu) 1979-12-03

Similar Documents

Publication Publication Date Title
NO170883B (no) Fremgangsmaate for fremstilling av 2-amino-5-hydroksy-4-metylpyrimidin-derivater
US4305944A (en) N-[(4-[3-cyano substituted pyridyl]piperazino)alkyl]-azaspirodecanediones
CS202506B2 (en) Process for preparing new 2-pyridyl- a 2-pyrimidylaminobenzoic acids
KR860001578B1 (ko) 3-티오메틸 파리딘 유도체의 제조방법
JPH0380795B2 (hu)
JPS62252780A (ja) 新規なインデノチアゾ−ル誘導体及びその製造法
JP3873173B2 (ja) ビス−2−アミノピリジン類、その製造方法及び寄生虫感染を制御するためのその用途
CS212264B2 (en) Method of making the 5-m-tolyloxyuracile
US4205073A (en) Anti-diarrheal anilino nicotinic acids and method of using same
US4808618A (en) Substituted 1,3-dialkylpyrido[4,3-d]pyrimidine-2,4-diones
HU181608B (en) Process for producing imidazo-thieno-pyrimidine derivatives
EP0200450A2 (en) Tricyclic derivativesof thiadiazole oxides
JPS60142968A (ja) 新規ジアジン−エテニルフエニルオキサミン酸
JPH0317083A (ja) 置換チエノピリミジン誘導体
JPH0451554B2 (hu)
JPS61260018A (ja) 抗アレルギ−剤
DE60023703T2 (de) Vorprodukte von bis-quaternären ammoniumsalzen und deren verwendung als prodrugs mit anti-parasitärer wirkung
KR820001542B1 (ko) 2-피리딜-및 2-피리미딜아미노 벤조산류의 제조방법
US4772704A (en) 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity
US3288793A (en) 2-tetrahydrofurfuryl-, 2-aliphatic-, and 2-aliphatic ether-sulfonamido-5-alkoxy-pyrimidines
EP0206623B1 (en) Pyridine derivatives
EP0011857B1 (en) 2-chloro-4-(4-lower alkyl-1-piperazinyl)-benzenemethanol-nw-oxides, methods for their preparation and pharmaceutical compositions containing them
CN112209899A (zh) 苯并硒唑酮类化合物及其应用和一种杀菌剂
JPS62198684A (ja) 3−(1H−テトラゾ−ル−5− イル) チエノ〔2,3−d〕 ピリミジン−4(3H)−オン類
NO152750B (no) Fremgangsmaate for fremstilling av nitrogen brohode-kondenserte pyrimidinforbindelser